Cancer Immunology, Immunotherapy

, Volume 63, Issue 7, pp 749–755 | Cite as

Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14–16, 2013

  • Björn-Philipp Kloke
  • Richard Rae
  • Andrea Mahr
  • Ute E. Burkhardt
  • Pia Kvistborg
  • Cedrik M. Britten
Meeting Report
  • 319 Downloads

Keywords

CIMT 2013 Cancer immunotherapy Meeting report Targeted therapies 

Notes

Acknowledgments

The authors would like to thank Dr. Stephen Reece (Mainz, Germany) for carefully proofreading the meeting report. Ute E. Burkhardt acknowledges support from the German Research Foundation (BU 3028/1-1). Selected sessions of the CIMT meeting were made possible due to research grants from the German Bundesministerium für Bildung and Forschung (BMBF grant: 031A018) and the Deutsche Forschungsgemeinschaft (DFG grant: GZ: HU 852/4-1; AOBJ: 602849). The CIMT-working group CIP receives support for educational activities by the Wallace Coulter Foundation (Florida, USA).

Conflict of interest

The authors declare that they have no conflict of interest. Cedrik M. Britten has been co-organizer of the meeting. Björn-Philipp Kloke has been co-organizer of the CIMT Endeavour workshop.

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Björn-Philipp Kloke
    • 1
  • Richard Rae
    • 2
  • Andrea Mahr
    • 3
  • Ute E. Burkhardt
    • 4
  • Pia Kvistborg
    • 5
  • Cedrik M. Britten
    • 1
    • 2
  1. 1.Ribological GmbHMainzGermany
  2. 2.Translational Oncology (TRON) at the University Medical CenterJohannes Gutenberg UniversityMainzGermany
  3. 3.Immatics Biotechnologies GmbHTübingenGermany
  4. 4.Department of Medical Oncology, Cancer Vaccine CenterDana–Farber Cancer InstituteBostonUSA
  5. 5.The Netherlands Cancer InstituteAmsterdamThe Netherlands

Personalised recommendations